Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

Table 1 Demographic and clinical characteristics for the modified intent to treat population.

Characteristic	n (%)
Total treated	418
Gender	241 (57.7)
Male	177 (42.3)
Female
Age, years	45.0 [13–92]
Median range
< 65	362 (86.6)
≥ 65	56 (13.4)
BMI	417
Mean ± SD	26.9 ± 6.9
Smoking status
Smoker	160 (38.3)
Ex-smoker	79 (18.9)
Nonsmoker	179 (42.8)
Chest x-ray findings
Unilateral	304 (73.6)
Bilateral	109 (26.4)
Single lobe*	351 (85.0)
Multiple lobe	54 (13.1)
Pleural effusion	15 (3.6)
Bacteremia	15 (3.6)
S pneumoniae bacteremia	9 (2.2)
Investigator assessment of current episode
Mild	93 (22.2)
Moderate	279 (66.7)
Severe	46 (11.0)
PSI
Class I	222 (53.1)
Class II	144 (34.4)
Class III	39 (9.3)
Class IV	12 (2.9)
Class V	1 (0.2)

BMI = body mass index; PSI = pneumonia severity index; SD = standard deviation.
*"Single lobe" could apply to either unilateral or bilateral lung involvement (i.e. 1 lobe per right and/or left lung).

ISSN: 1471-2334